Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Alzheimer's Disease

  Free Subscription


Articles published in J Am Geriatr Soc

Retrieve available abstracts of 49 articles:
HTML format



Single Articles


    April 2020
  1. HSHIEH TT, Fong TG, Schmitt EM, Marcantonio ER, et al
    Does Alzheimer's Disease and Related Dementias Modify Delirium Severity and Hospital Outcomes?
    J Am Geriatr Soc. 2020 Apr 7. doi: 10.1111/jgs.16420.
    PubMed     Abstract available


    February 2020
  2. REN D, Lopez OL, Lingler JH, Conley Y, et al
    The Effect of the APOE epsilon2epsilon4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
    J Am Geriatr Soc. 2020 Feb 4. doi: 10.1111/jgs.16337.
    PubMed     Abstract available


    January 2020
  3. TAPIAINEN V, Lavikainen P, Koponen M, Taipale H, et al
    The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.
    J Am Geriatr Soc. 2020 Jan 7. doi: 10.1111/jgs.16275.
    PubMed     Abstract available


    December 2019
  4. KIRSON NY, Meadows ES, Desai U, Smith BP, et al
    Temporal and Geographic Variation in the Incidence of Alzheimer's Disease Diagnosis in the US between 2007 and 2014.
    J Am Geriatr Soc. 2019 Dec 3. doi: 10.1111/jgs.16262.
    PubMed     Abstract available


    November 2019
  5. BOUSTANI M, Perkins AJ, Khandker RK, Duong S, et al
    Passive Digital Signature for Early Identification of Alzheimer's Disease and Related Dementia.
    J Am Geriatr Soc. 2019 Nov 29. doi: 10.1111/jgs.16218.
    PubMed     Abstract available


    October 2019
  6. FONG TG, Racine AM, Fick DM, Tabloski P, et al
    The Caregiver Burden of Delirium in Older Adults With Alzheimer Disease and Related Disorders.
    J Am Geriatr Soc. 2019 Oct 12. doi: 10.1111/jgs.16199.
    PubMed     Abstract available


  7. LEE WJ, Liao YC, Wang YF, Lin YS, et al
    Summative Effects of Vascular Risk Factors on the Progression of Alzheimer Disease.
    J Am Geriatr Soc. 2019 Oct 6. doi: 10.1111/jgs.16181.
    PubMed     Abstract available


    July 2019
  8. REUBEN DB, Tan ZS, Romero T, Wenger NS, et al
    Patient and Caregiver Benefit From a Comprehensive Dementia Care Program: 1-Year Results From the UCLA Alzheimer's and Dementia Care Program.
    J Am Geriatr Soc. 2019 Jul 29. doi: 10.1111/jgs.16085.
    PubMed     Abstract available


    June 2019
  9. GAO S, Burney HN, Callahan CM, Purnell CE, et al
    Incidence of Dementia and Alzheimer Disease Over Time: A Meta-Analysis.
    J Am Geriatr Soc. 2019 Jun 20. doi: 10.1111/jgs.16027.
    PubMed     Abstract available


  10. NIZNIK JD, Zhao X, He M, Aspinall SL, et al
    Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia.
    J Am Geriatr Soc. 2019 Jun 4. doi: 10.1111/jgs.15985.
    PubMed     Abstract available


    March 2019
  11. MARCUM ZA, Walker R, Bobb JF, Sin MK, et al
    Reply to: Comment on: Serum Cholesterol and Incident Alzheimer's Disease: Findings From the Adult Changes in Thought Study.
    J Am Geriatr Soc. 2019 Mar 20. doi: 10.1111/jgs.15879.
    PubMed    


  12. NAHARCI MI, Tasci I
    Comment on: Serum Cholesterol and Incident Alzheimer Disease: Findings From the Adult Changes in Thought Study.
    J Am Geriatr Soc. 2019 Mar 20. doi: 10.1111/jgs.15877.
    PubMed    


  13. CHOI S, Kim K, Chang J, Kim SM, et al
    Association of Chronic Periodontitis on Alzheimer's Disease or Vascular Dementia.
    J Am Geriatr Soc. 2019 Mar 15. doi: 10.1111/jgs.15828.
    PubMed     Abstract available


  14. ZHAO HL, Huang YM
    Reply to: Why Amyloid Is Still a Target for Alzheimer's Disease.
    J Am Geriatr Soc. 2019 Mar 9. doi: 10.1111/jgs.15827.
    PubMed    


  15. HUANG YM, Shen J, Zhao HL
    Major Clinical Trials Failed the Amyloid Hypothesis of Alzheimer's Disease.
    J Am Geriatr Soc. 2019 Mar 9. doi: 10.1111/jgs.15830.
    PubMed    


  16. MCDADE E
    Reply to: Major Clinical Trials Failed the Amyloid Hypothesis of Alzheimer's Disease.
    J Am Geriatr Soc. 2019 Mar 9. doi: 10.1111/jgs.15826.
    PubMed    


  17. MCDADE E
    Why Amyloid Is Still a Target for Alzheimer disease Clinical Trials.
    J Am Geriatr Soc. 2019 Mar 9. doi: 10.1111/jgs.15829.
    PubMed    


    February 2019
  18. ZAROWITZ BJ, Tisdale JE
    Navigating the Minefield of QTc Interval-Prolonging Therapy in Nursing Facility Residents.
    J Am Geriatr Soc. 2019 Feb 12. doi: 10.1111/jgs.15810.
    PubMed     Abstract available


    January 2019
  19. ROYALL DR
    Comment on Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia.
    J Am Geriatr Soc. 2019 Jan 11. doi: 10.1111/jgs.15752.
    PubMed    


    November 2018
  20. VASSILAKI M, Aakre JA, Kremers WK, Mielke MM, et al
    Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia.
    J Am Geriatr Soc. 2018 Nov 21. doi: 10.1111/jgs.15577.
    PubMed     Abstract available


  21. GRIMMER T, Licata A
    Functional Decline in Alzheimer's Disease: A Continuum.
    J Am Geriatr Soc. 2018 Nov 21. doi: 10.1111/jgs.15668.
    PubMed    


    October 2018
  22. ROITTO HM, Kautiainen H, Ohman H, Savikko N, et al
    Relationship of Neuropsychiatric Symptoms with Falls in Alzheimer's Disease - Does Exercise Modify the Risk?
    J Am Geriatr Soc. 2018 Oct 15. doi: 10.1111/jgs.15614.
    PubMed     Abstract available


  23. MARCUM ZA, Walker R, Bobb JF, Sin MK, et al
    Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study.
    J Am Geriatr Soc. 2018 Oct 5. doi: 10.1111/jgs.15581.
    PubMed     Abstract available


    September 2018
  24. LILAMAND M, Cesari M, Cantet C, Payoux P, et al
    Relationship Between Brain Amyloid Deposition and Instrumental Activities of Daily Living in Older Adults: A Longitudinal Study from the Multidomain Alzheimer Prevention Trial.
    J Am Geriatr Soc. 2018 Sep 12. doi: 10.1111/jgs.15497.
    PubMed     Abstract available


    August 2018
  25. LIAO KF, Chuang HY, Lai SW
    Association Between Proton Pump Inhibitor Use and Alzheimer's Disease in Older Adults.
    J Am Geriatr Soc. 2018 Aug 10. doi: 10.1111/jgs.15474.
    PubMed    


  26. GOLDSTEIN FC
    Reply to: Association Between Proton Pump Inhibitors and Alzheimer's Disease in Older Adults.
    J Am Geriatr Soc. 2018 Aug 10. doi: 10.1111/jgs.15498.
    PubMed    


    May 2018
  27. OLTRA-CUCARELLA J, Sanchez-SanSegundo M, Lipnicki DM, Sachdev PS, et al
    Using Base Rate of Low Scores to Identify Progression from Amnestic Mild Cognitive Impairment to Alzheimer's Disease.
    J Am Geriatr Soc. 2018 May 10. doi: 10.1111/jgs.15412.
    PubMed     Abstract available


    April 2018
  28. DEHN LB, Boedeker S, Nienhaus M, Labudda K, et al
    Whether to Ask: How Valid Are Memory Complaints in Alzheimer's Disease?
    J Am Geriatr Soc. 2018 Apr 27. doi: 10.1111/jgs.15373.
    PubMed    


    March 2018
  29. KHANDKER RK, Black CM, Xie L, Kariburyo MF, et al
    Analysis of Episodes of Care in Medicare Beneficiaries Newly Diagnosed with Alzheimer's Disease.
    J Am Geriatr Soc. 2018 Mar 30. doi: 10.1111/jgs.15281.
    PubMed     Abstract available


  30. VAUGHAN RM, Coen RF, Kenny R, Lawlor BA, et al
    Semantic and Phonemic Verbal Fluency Discrepancy in Mild Cognitive Impairment: Potential Predictor of Progression to Alzheimer's Disease.
    J Am Geriatr Soc. 2018 Mar 23. doi: 10.1111/jgs.15294.
    PubMed     Abstract available


    February 2018
  31. FAES K, Cohen J, Annemans L
    Resource Use During the Last 6 Months of Life of Individuals Dying with and of Alzheimer's Disease.
    J Am Geriatr Soc. 2018 Feb 15. doi: 10.1111/jgs.15287.
    PubMed     Abstract available


    January 2018
  32. PANZA GA, Taylor BA, MacDonald HV, Johnson BT, et al
    Can Exercise Improve Cognitive Symptoms of Alzheimer's Disease? A Meta-Analysis.
    J Am Geriatr Soc. 2018 Jan 24. doi: 10.1111/jgs.15241.
    PubMed     Abstract available


    September 2017
  33. TRICCO AC, Ashoor HM, Soobiah C, Rios P, et al
    Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer's Disease: Systematic Review and Network Metaanalysis.
    J Am Geriatr Soc. 2017 Sep 29. doi: 10.1111/jgs.15069.
    PubMed     Abstract available


  34. CHENG HT, Lin FJ, Erickson SR, Hong JL, et al
    The Association Between the Use of Zolpidem and the Risk of Alzheimer's Disease Among Older People.
    J Am Geriatr Soc. 2017 Sep 7. doi: 10.1111/jgs.15018.
    PubMed     Abstract available


  35. GOLDSTEIN FC, Steenland K, Zhao L, Wharton W, et al
    Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia.
    J Am Geriatr Soc. 2017;65:1969-1974.
    PubMed     Abstract available


    August 2017
  36. ISAACSON R
    Is Alzheimer's Prevention Possible Today?
    J Am Geriatr Soc. 2017 Aug 28. doi: 10.1111/jgs.15060.
    PubMed    


  37. MEHTA N, Rodrigues C, Lamba M, Wu W, et al
    Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example.
    J Am Geriatr Soc. 2017 Aug 18. doi: 10.1111/jgs.15020.
    PubMed     Abstract available


  38. SANO M, Zhu CW, Grossman H, Schimming C, et al
    Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data.
    J Am Geriatr Soc. 2017 Aug 3. doi: 10.1111/jgs.15014.
    PubMed     Abstract available


  39. GALVIN JE
    Prevention of Alzheimer's Disease: Lessons Learned and Applied.
    J Am Geriatr Soc. 2017 Aug 2. doi: 10.1111/jgs.14997.
    PubMed     Abstract available


    July 2017
  40. CANEVELLI M, Cesari M, Lucchini F, Valletta M, et al
    Need to Recalibrate Research Outcomes in Alzheimer's Disease: Focus on Neuropsychiatric Symptoms.
    J Am Geriatr Soc. 2017 Jul 6. doi: 10.1111/jgs.14989.
    PubMed     Abstract available


    June 2017
  41. FARIAS ST, Lau K, Harvey D, Denny KG, et al
    Early Functional Limitations in Cognitively Normal Older Adults Predict Diagnostic Conversion to Mild Cognitive Impairment.
    J Am Geriatr Soc. 2017;65:1152-1158.
    PubMed     Abstract available


  42. SHAFI MM, Santarnecchi E, Fong TG, Jones RN, et al
    Advancing the Neurophysiological Understanding of Delirium.
    J Am Geriatr Soc. 2017;65:1114-1118.
    PubMed     Abstract available


    May 2017
  43. CALLAHAN CM
    Alzheimer's Disease: Individuals, Dyads, Communities, and Costs.
    J Am Geriatr Soc. 2017 May 5. doi: 10.1111/jgs.14808.
    PubMed     Abstract available


  44. BERGERON D, Flynn K, Verret L, Poulin S, et al
    Multicenter Validation of an MMSE-MoCA Conversion Table.
    J Am Geriatr Soc. 2017;65:1067-1072.
    PubMed     Abstract available


    April 2017
  45. EZZATI A, Wang C, Lipton RB, Altschul D, et al
    Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology.
    J Am Geriatr Soc. 2017 Apr 13. doi: 10.1111/jgs.14903.
    PubMed     Abstract available


    March 2017
  46. CAMPBELL NL, Perkins AJ, Gao S, Skaar TC, et al
    Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial.
    J Am Geriatr Soc. 2017 Mar 14. doi: 10.1111/jgs.14827.
    PubMed     Abstract available


    January 2017
  47. CHEN LH, Fan YH, Kao PY, Ho DT, et al
    Genetic Polymorphisms in Estrogen Metabolic Pathway Associated with Risks of Alzheimer's Disease: Evidence from a Southern Chinese Population.
    J Am Geriatr Soc. 2017 Jan 19. doi: 10.1111/jgs.14537.
    PubMed     Abstract available


    November 2016
  48. S VANN A
    Reporting Deaths of Individuals with Alzheimer's Disease.
    J Am Geriatr Soc. 2016 Nov 8. doi: 10.1111/jgs.14555.
    PubMed    


  49. DING X, Kryscio RJ, Turner J, Jicha GA, et al
    Self-Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial.
    J Am Geriatr Soc. 2016 Nov 1. doi: 10.1111/jgs.14393.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: